Education
About Us
Working with TipRanks
Follow Us
Sleep Number (SNBR)
NASDAQ:SNBR
Top Page
Sleep Number
(NASDAQ:SNBR)41Neutral
Sleep Number (SNBR) vs. S&P 500 (SPY)
Market Cap
$288.36M
Dividend YieldN/A
Average Volume (3M)448.79K
Price to Earnings (P/E)―
Beta (1Y)2.32
Revenue Growth-11.28%
EPS Growth-1004.59%
CountryUS
Employees4,054
SectorConsumer Cyclical
Sector Strength53
IndustryHome and Homeware
Share Statistics
EPS (TTM)-0.90
Shares Outstanding22,371,000
10 Day Avg. Volume821,288
30 Day Avg. Volume448,792
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.17
Price to Cash Flow (P/CF)2.60
P/FCF Ratio3.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$11.50Price Target Upside51.92% Upside
Rating ConsensusHold
Number of Analyst Covering3
Sleep Number Business Overview & Revenue Model
Company DescriptionSleep Number Corporation (SNBR) is an American manufacturer and retailer that specializes in innovative sleep solutions. Founded in 1987 and headquartered in Minneapolis, Minnesota, the company is renowned for its Sleep Number beds, which feature adjustable firmness settings and sleep tracking technology. Sleep Number operates primarily in the retail sector, selling its products through company-owned stores, online channels, and third-party retail partners. Its product line includes not only customizable mattresses but also bedding accessories and sleep technology products.
How the Company Makes MoneySleep Number Corporation generates revenue primarily through the sale of its Sleep Number mattresses and adjustable bases, which are its flagship products. The company utilizes a direct-to-consumer model, selling products through its own retail stores, e-commerce platform, and select retail partners. A significant revenue stream comes from the sale of sleep-related accessories, such as pillows, bedding, and mattress pads. Furthermore, Sleep Number leverages its proprietary SleepIQ technology, which offers sleep tracking and analytics, adding value to its product offerings and driving customer engagement. The company also benefits from its brand recognition and customer loyalty programs, which help maintain a strong market presence and encourage repeat purchases.
Sleep Number Financial Statement Overview
Summary
Sleep Number is facing financial pressures with declining revenues, negative profitability, and a highly leveraged balance sheet. While gross margins are relatively strong, overall financial health is compromised by negative equity and cash flow challenges, necessitating strategic measures to stabilize and improve financial performance.Income Statement
Sleep Number's income statement reveals a challenging period with declining revenues (TTM: $1.73B vs. $2.11B previous year) and negative net income (TTM Net Income: -$40.86M). The gross profit margin remains robust at 59.42% in TTM, but the net profit margin is negative at -2.35%. The EBIT margin has also decreased to 1.65% from 3.59% last year, indicating reduced operational efficiency.45
Neutral
Balance Sheet
The balance sheet shows a concerning financial structure with negative stockholders' equity (TTM: -$448.78M), indicating potential financial distress. The debt-to-equity ratio is not calculable due to negative equity, which presents a significant risk. Total liabilities exceed assets, suggesting a highly leveraged position that could impact long-term viability.30
Negative
Cash Flow
The cash flow statement highlights a negative free cash flow (TTM: -$17.87M), though there is a slight improvement from the previous year's -$66.08M. The operating cash flow to net income ratio is positive at 0.21, indicating some capability to generate cash from operations despite losses, but overall cash flow management remains a concern.38
Negative
| Breakdown | |||||
| TTM | Dec 2023 | Dec 2022 | Mar 2022 | Mar 2021 | Dec 2019 |
|---|---|---|---|---|---|
| Income Statement | Total Revenue | ||||
| 1.73B | 1.89B | 2.11B | 2.18B | 1.86B | 1.70B | Gross Profit |
| 1.03B | 1.09B | 1.20B | 1.32B | 1.16B | 1.05B | EBIT |
| 28.64M | 22.94M | 67.88M | 193.54M | 184.90M | 112.09M | EBITDA |
| 80.94M | 95.34M | 135.28M | 253.93M | 246.46M | 173.96M | Net Income Common Stockholders |
| -40.86M | -15.29M | 36.61M | 153.75M | 139.19M | 81.84M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
| 1.61M | 2.54M | 1.79M | 2.39M | 4.24M | 1.59M | Total Assets |
| 470.14M | 950.88M | 953.94M | 919.54M | 800.14M | 806.04M | Total Debt |
| 199.60M | 972.65M | 896.01M | 791.05M | 589.36M | 588.65M | Net Debt |
| 197.99M | 970.12M | 894.22M | 788.66M | 585.12M | 587.06M | Total Liabilities |
| 579.69M | 1.39B | 1.39B | 1.34B | 1.02B | 965.47M | Stockholders Equity |
| -109.55M | -441.93M | -438.18M | -424.95M | -223.98M | -159.43M |
| Cash Flow | Free Cash Flow | ||||
| -17.86M | -66.08M | -33.32M | 233.11M | 240.59M | 129.92M | Operating Cash Flow |
| 8.39M | -9.03M | 36.14M | 300.01M | 279.66M | 189.16M | Investing Cash Flow |
| -29.03M | -58.35M | -70.61M | -66.64M | -39.02M | -56.62M | Financing Cash Flow |
| 21.33M | 68.13M | 33.87M | -235.22M | -237.99M | -132.56M |
Sleep Number Technical Analysis
Negative
7.57
Price Trends
15.77
Negative
15.55
Negative
14.47
Negative
Market Momentum
-1.85
Positive
19.33
Positive
10.74
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SNBR, the sentiment is Negative. The current price of 7.57 is below the 20-day moving average (MA) of 14.58, below the 50-day MA of 15.77, and below the 200-day MA of 14.47, indicating a bearish trend. The MACD of -1.85 indicates Positive momentum. The RSI at 19.33 is Positive, neither overbought nor oversold. The STOCH value of 10.74 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SNBR.
Sleep Number Risk Analysis
Sleep Number disclosed 30 risk factors in its most recent earnings report. Sleep Number reported the most risks in the “Production” category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Sleep Number Peers Comparison
Overall Rating
UnderperformOutperform
Sector (60)
Financial Indicators
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | $1.74B | 14.44 | 12.40% | 1.95% | 1.81% | 8.09% | |
72 Outperform | ― | 68.75% | ― | 0.11% | 3.48% | ||
67 Neutral | $7.40B | 14.39 | 6.82% | ― | -2.68% | ― | |
60 Neutral | $1.17B | ― | -50.56% | 7.09% | -7.28% | -272.76% | |
60 Neutral | $13.01B | 10.45 | 0.79% | 3.53% | 1.60% | -22.47% | |
51 Neutral | $78.95M | ― | -134.32% | ― | -2.04% | 40.57% | |
41 Neutral | $288.36M | ― | 9.10% | ― | -11.28% | -1004.59% |
* Consumer Cyclical Sector Average
Performance Comparison
SNBR
Sleep Number
7.57
-9.42
-55.44%
LZB
La-Z-Boy Incorporated
41.57
5.72
15.96%
LEG
Leggett & Platt
8.62
-11.10
-56.29%
MHK
Mohawk
117.01
-4.65
-3.82%
SGI
―
―
―
―
PRPL
Purple Innovation
0.74
-1.21
-62.05%
Sleep Number Earnings Call Summary
Earnings Call Date: Mar 5, 2025 | % Change Since: -41.27% | Next Earnings Date: Apr 23, 2025
Earnings Call Sentiment Neutral
The earnings call highlighted significant improvements in EBITDA and gross margin due to effective cost management and operational efficiency. However, these positives were offset by declines in net sales and challenging market conditions, including weakened consumer sentiment and economic pressures.Highlights
Significant EBITDA Growth
Delivered a 43% year-over-year increase in fourth quarter adjusted EBITDA, with a full year adjusted EBITDA of $120 million, in line with the midpoint of guidance.
Gross Margin Improvement
Fourth quarter gross margin reached 59.9%, resulting in a full year gross margin of 59.6%, a 190 basis point increase over 2023.
Cost Reductions Exceed Expectations
Achieved a $28 million year-over-year reduction in fourth quarter operating expenses, with 2024 full year cost reductions of $88 million, nearly double the initial targets.
Product Mix and Operational Efficiency
Favorable product mix and cost efficiencies, including material cost reductions and supplier negotiations, contributed to the gross margin increase.
Lowlights
Decline in Net Sales
Fourth quarter net sales declined 12% year-over-year to $377 million, slightly below expectations.
Challenging Consumer Environment
Consumer sentiment dropped further in February 2025, with a significant 19% drop in buying conditions for durables.
Tariff and Economic Pressure
Potential tariffs were announced, and inflation concerns returned, affecting consumer purchasing power.
Store Count Reduction Impact
Fourth quarter net sales included 1 to 2 points of pressure due to a 5% reduction in stores year-over-year.
Company Guidance
In the Sleep Number Q4 and Full Year 2024 earnings call, the company reported a 43% year-over-year increase in fourth quarter adjusted EBITDA, reaching $120 million for the full year, aligning with the midpoint of their guidance. The gross margin improved to 59.9% in Q4, contributing to a full-year gross margin of 59.6%, a 190 basis point increase over 2023. However, Q4 net sales declined 12% year-over-year to $377 million. The company reduced media spend by 18% in Q4 and 9% for the year, aiming to maximize EBITDA amidst challenging market conditions. Operational efficiency improvements resulted in a $28 million reduction in Q4 operating expenses and $88 million in cost reductions for the year. Sleep Number's demand year-to-date in 2025 remains down double digits, with ongoing macroeconomic challenges affecting consumer sentiment and spending. The company has amended its 2025 financial covenants for increased flexibility and is exploring debt restructuring options.Sleep Number Corporate Events
Financial Disclosures
Sleep Number to Release Q4 and 2024 Earnings
Neutral
Feb 18, 2025
On February 18, 2025, Sleep Number Corporation announced its upcoming fiscal fourth quarter and full year 2024 earnings results release and conference call scheduled for March 5, 2025. The announcement is significant for stakeholders as it provides insights into the company’s financial health and operational performance, potentially impacting market perceptions and investor decisions.
Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.